Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hydatidiform Mole × Letrozole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Polycystic Ovary Syndrome 2 Uterine Neoplasms 1 Neoplasm Metastasis 1 Inflammatory Breast Neoplasms 1 Infertility 1 Hydatidiform Mole 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Gestational Trophoblastic Disease 1 Endometrial Neoplasms 1 Carcinoma, Ductal, Breast 1

Interventions

Vacuum Curettage 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡